Progress in Neuro-Psychopharmacology & Biological Psychiatry
Elsevier Inc. · England
Metrics
- Impact factor
- 4.2+0.3 Clarivate JCR
- WoS quartile
- Q1 Clarivate JCR, best category
- SJR
- 1.502Q1 SCImago
- h-index
- 114
- CAS tier
- Tier 2 Chinese Academy of Sciences
- Citations per paper
- 4.93 last 2 years
- Articles per year
- 374
- Self-citation
- 3.8%
- Fee (APC), est.
- $3,617 estimated, check the journal
About this journal
- ISSN
- 0278-5846 (print) · 1878-4216 (online)
- Publisher
- Elsevier Inc. · Elsevier
- Country
- England · Northern America
- Indexed in
- SCIE
- Access
- Hybrid · 26.8% gold OA
- Founded
- 1982
- Frequency
- Bimonthly
- Original research
- 90.8%
- Subject areas
- Neuroscience, Pharmacology, Toxicology and Pharmaceutics
- Categories
- Medicine, Psychiatry
- Common topics
- Medicine, Biology, Psychology, Internal medicine, Psychiatry
Similar journals
- Q1WoS
Neuron
Impact factor 16.9h-index 430SJR 8.56 - Q1WoS
Journal of Neuroscience
Impact factor 4.3h-index 422SJR 1.84 - Q1WoS
Nature Neuroscience
Impact factor 20.3h-index 375SJR 11.04 - Q1WoS
EMBO Journal
Impact factor 8.4h-index 368SJR 4.41 - Q1WoS
Nature Reviews Neuroscience
Impact factor 29h-index 357SJR 10.28 - Q1WoS
Neuroimage
Impact factor 5.3h-index 320SJR 1.93
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals